Abstract
Metformin is the cornerstone in the treatment of diabetes and is the most frequently prescribed as the first line therapy for individuals with type 2 diabetes. Objective: To determine the correlation between vitamin B 12 and metformin in diabetes mellitus type II patients treated by metformin in Southern Gaza. Methodology and tools This case control descriptive study comprised of 80 diabetic participants divided equally into two groups: experimental group, 40 diabetics patients taking metformin, and control group, 40 diabetics not taking metformin, aged between 50-95years old. Interviews were conducted. Serum vitamin B12 and CBC were measured. Data were analyzed using SPSS version 20. Results: VitaminB 12 deficiency was present in 30% of the cases and non apparent in the control group had deficient vitaminB12. There were statistically significant negative association between dose and vitamine B12. Besides, there was statistically significant negative association between duration and vitamine B12, by means of an increase in duration will lead to decrease in vitamin B12 level. Blood rofile analysis showed a statistically significant positive association between vitamin B12 and Hb, WBC , RBC and PLT; vitamin B12 decrease will lead to a decrease in Hb, WBC, RBC and PLT at (be less than 0.05). Conclusion: Vitamin B 12 deficiency occurs more frequently in patients with type 2 diabetes with longer duration of metformin use and in those taking larger amounts of metformin. There was a clear side effect of metformin use on most of blood indices. Key words: Metformin, Diabetes Type-2, Vitamin B12
1-Introduction:
Metformin (Glucophage) is a popular and highly effective oral diabetes drug used to help management of Type 2 diabetes. This drug works by lowering the amount of glucose made by the liver and by making the body's cells more sensitive to insulin. Metformin also has some other beneficial effects that may lower blood lipids; (cholesterol and triacylglycerols) and, in Metformin is a cornerstone in the treatment of diabetes and is the most frequently prescribed first line therapy for individuals with type 2 diabetes (Kirpichnikov et al., 2002) . It is one of a few antihyperglycaemic agents associated with improvements in cardiovascular morbidity and mortality, which is a major cause of death in patients with type 2 diabetes al., 1988) . As metformin has been prescribed worldwide and treatment periods increased, the prevalence of metformin-induced vitamin B 12 deficiency may have also significantly increased. However, the relationship between metformin use and vitamin B 12 deficiency in the Asian population has not been widely investigated Significance Diabetes mellitus type II is a common disease in the Palestinian community and considered as one of the health problems among patients in Southern Gaza. Metformin seems to be an etiologic factor in vitamin B 12 deficiency. This study brought into focus this health problem. Objective The general goal of the study is to determine the correlation between metformin, vitamin B 12 level and blood indices, in type-2 diabetics.
2-Materials and methods:
Study design and samples: The present study is descriptive case control study. The population of the study includes patients suffering from Diabetes mellitus type 2 aged over 50 years old in Southern Gaza. The sample of the study consisted of 80 patients divided equally into two groups; case group, consisting of 40 patients with Diabetes mellitus type 2 taking metformin , and control group, consisting of 40 diabetics not taking metformin. The study was conducted in the main public hospitals: Nasser Hospital, Gaza European Hospital in Khanyounis, and Al-Najar Hospital in Rafah. The study was carried out during the period of February-June 2016. Inclusion and exclusion criteria: Known patients with Diabetes mellitus type 2. Age between 50-93 years. Patients with renal or liver diseases, endocrine disorders, malabsorption syndrome, gastrectomy, non-vegetarians, Pregnant women, tobacco and drug users like-Antacids, vitamin B12 supplements (either oral or parenteral within last 2-3 years), Fibrec Acid Derivatives, Thiozolidinediones, insulin were excluded (Twinkal et al., 2016). Ethical considerations and permissions: Each patient is given informed consent to get approval for his or her patient participation in this study and the objective of the study is explained to patients. Data collection: An interview was used for filling in questionnaires delete designed for matching the study need of the study population. All interviews were conducted face to face by the researchers. Blood Collection: All blood samples were collected in a lavender top tube (EDTA) and serum taken from patients, and sent to the laboratory within 2 hours. EDTA tube were collected and tested during 2 hours. Hemolysed sample is rejected, and sample tubes were allowed to reach room temperature (15-30°C) before performing the assay. Complete blood count (CBC) CBC was performed on all samples including: white blood cell count (WBC), red blood cell count (RBC), hemoglobin (Hb), hematocrit (HCT), mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), mean corpuscular hemoglobin concentration (MCHC), red cell distribution width (RDW), and platelets (PLT) using cell dyne 1800 (Germany) for analysis (Heymann et al., 1977) Biochemical analysis Determination of Serum Vitamin B 12 Vitamin B12 is determined quantitatively using ELISA (Snow, 1999) .
Expected Values for Vitamin B12: Adult: 200 -835 pg/ml, level of ≤ 200 pg/ml considered as low. Statistical analysis: Data were analyzed using SPSS/ PC, Statistical
Package for the Social Sciences, version 20.0. Simple distribution of the study variables and the cross tabulation were applied. Chi-square was used to identify the significance of the relations, associations, and interactions among various variables. Pearson's correlation test was applied. The results in all the above mentioned procedures were accepted as Statistically significant when the p-value was less than 5% (p<0.05). SPSS program version 20.0 was used for correlation graphs plotting
3-Results and Discussion
Socio-demographic characteristics of study participants: Table (1) showed the socio demographic characteristics of the study population. These results indicated that there were statistically insignificant differences between the two groups in their socio-demographic characteristics. (6) show statistically significant negative association between duration of metformin ingestion and vitamin B12 (p=0.000 r= -0.513). Table ( . This wide variation in the reported prevalence could probably be explained by the variability of measurement methods of vitamin B12 levels in the laboratories or may be due to variation in metformin dose and duration of ingestion (Akinlade et al., 2015 ). The present study shows a clear inverse relationship between the dosage or duration of metformin use and vitamin B12 deficiency in patients with type 2 diabetes. According to correlation analysis, vitamin B12 deficiency was associated with metformin dosage and length of administration, it was not until 2006 that the increased risk of the vitamin B12 deficiency with metformin was rediscovered through a case control study of Chinas patients, which showed a correlation between the dose and duration of metformin use with vitamin B12 deficiency (Bell, 2010). There is no known mechanism of metformin-induced vitamin B 12 deficiency but some hypotheses included bacterial overgrowth in the small intestine, which has been attributed to diabetes mellitus, changes in small bowel motility, changes in bacterial flora, competitive inhibition or inactivation of vitamin B 12 absorption, or an effect of calcium on cell membranes ( The more likely explanation for metformin induced vitamin B12 deficiency is that metformin has an effect on calcium dependent membrane action in the terminal ilium. Absorbtion of vitamin B12-intrinsic factor complex in calcium dependent and metformin interferes with this absorption. Dietary calcium supplementation referees metformin induced vitamin B12 malabsorption, which supports the previous hypothesis (Bell, 2010). Chronic metformin use results in vitamin B12 deficiency and the exhaustion of vitamin B12 stores usually occurs after twelve to fifteen years of absolute vitamin B12 deficiency. Vitamin B12 malabsorption is a chronic complication of metformin therapy, which can result in irreversible neuronal damage. On metformin therapy vitamin b12 levels should be checked on an annual basis (Pflipsen et al ., 2009; and Bell, 2010 ). An alternative and a more practical and cost-effective method to avoid vitamin B12 deficiency would be an annual vitamin B12 injection that would provide more than the annual vitamin B12 needs for every patient on chronic metformin therapy (Niafar et al., 2015 and Aroda et al., 2016) . Furthermore, a daily multivitamin may protect against B12 deficiency (Pflipsen et al ., 2009 ). Long term use of metformin was associated with biochemical B12 deficiency and anemia. Routine testing of vitamin b12 levels in metformin treated patients should be considered (Aroda et al., 2016) . Also the result of the present study shows a clear effect of metformin on decreasing of RBCs, WBCs, MCH and Hb levels. Aroda and others, result is in agreement with the present work result of blood indices. This may be due to the role of vitamin B12 in blood indices formation and Rbc's metabolism. Conclusion The present work recorded that vitamin B 12 deficiency occurs more frequently in type 2 diabetics with longer duration of metformin use and in those taking larger amounts of metformin. There was no significant association between gender and Vitamin B12 levels among cases and controls.. The present study suggested the need for regular CBC and vitamin B 12 monitoring in type 2 diabetics receiving metformin.
